In partnership with
First-in-class P2X3 receptor antagonist shows efficacy in chronic cough
Structured follow-up to detect persisting pulmonary impairment in COVID-19 survivors
Smartphone app measuring night-time coughing successfully predicts asthma deterioration
Reduced lung function associated with cognitive decline
Bronchoscopies may add diagnostic value in certain COVID-19 patients
COVID-19: Who is threatened by secondary pulmonary fibrosis?
Pulmonary rehabilitation should start as early as possible after a COVID-19 infection
Physical activity improves AHI in sleep apnoea patients
Nasal high-flow therapy: a novel treatment option for patients with chronic hypercapnic COPD
Low intensity smoking – an underestimated risk?
IL-4/IL-13 blocker in asthma: sustained improvement in lung function and exacerbations
Antifibrotic combination therapy reduces biomarkers in patients with IPF and emphysema
COPD: Singing training as effective as physical rehabilitation
Poly-use of nicotine products: an underestimated lung hazard
First study on personalised asthma care shows signs of benefit
Top image: @ iStockPhoto: Tom Merton
The content and interpretation of these conference highlights are the views and comments of the speakers/ authors.
BACK TO TOP